Cargando…

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study

INTRODUCTION: The mainstay systemic treatment for non-oncogenic addictive advanced stage non-small cell lung cancer is chemotherapy. Anti-angiogenic agents are additive compounds that enhance disease control and lead to improvement of overall survival benefit. Recently PD-(L)1 blockage, a checkpoint...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korphaisarn, Krittiya, Danchaivijitr, Pongwut, Reungwetwattana, Thanyanan, Chewaskulyong, Busayamas, Thongthieang, Luangyot, Chindaprasirt, Jarin, Maneenil, Kunlatida, Sathitruangsak, Chirawadee, Vinayanuwattikun, Chanida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117590/ https://www.ncbi.nlm.nih.gov/pubmed/33996532 http://dx.doi.org/10.3389/fonc.2021.572740

Ejemplares similares

Efficacy, Safety, and Patient-Reported Outcomes of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Thailand: A Multicenter Prospective Study
por: Charonpongsuntorn, Chanchai, et al.
Publicado: (2022)

Differential expression of immune-regulatory proteins C5AR1, CLEC4A and NLRP3 on peripheral blood mononuclear cells in early-stage non-small cell lung cancer patients
por: Pakvisal, Nussara, et al.
Publicado: (2022)

Prevalence and Associated Factors for Thyroid Dysfunction Among Patients On Targeted Therapy for Cancers: A Single-Center Study from Thailand
por: Chawalitmongkol, Korawan, et al.
Publicado: (2023)

Nineteen-year, real-world experience of first-line combination chemotherapy in patients with metastatic colorectal cancer: a propensity score analysis from southern Thailand
por: Wonglhow, Jirapat, et al.
Publicado: (2023)

Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer
por: Sitthideatphaiboon, Piyada, et al.
Publicado: (2022)

Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinoma: a multicenter analysis in Thailand
por: Ngamphaiboon, Nuttapong, et al.
Publicado: (2020)

Hepatitis B screening rates and reactivation in solid organ malignancy patients undergoing chemotherapy in Southern Thailand
por: Laiwatthanapaisan, Ratchapong, et al.
Publicado: (2019)

Targeted therapies in development for non-small cell lung cancer
por: Reungwetwattana, Thanyanan, et al.
Publicado: (2013)

Metastatic Primary Testicular Neuroendocrine Carcinoma Associated with Somatic Malignant Transformation of Teratoma: A Rare Case Report
por: Wonglhow, Jirapat, et al.
Publicado: (2022)

Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience
por: Nopmaneepaisarn, Titaporn, et al.
Publicado: (2019)

Association of histologic subtypes with genetic alteration and PD-L1 expression in pulmonary adenocarcinoma
por: Phruttinarakorn, Bantita, et al.
Publicado: (2020)

Health Insurance and Colorectal Cancer Survival in Khon Kaen, Thailand
por: Phimha, Surachai, et al.
Publicado: (2019)

Association between Pathological Complete Response and Outcome Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients
por: Luangdilok, Sutima, et al.
Publicado: (2014)

Cost–Utility and Budget Impact Analyses of Oral Chemotherapy for Stage III Colorectal Cancer: Real-World Evidence after Policy Implementation in Thailand
por: Phisalprapa, Pochamana, et al.
Publicado: (2023)

Distinct and shared three‐dimensional chromosome organization patterns in lymphocytes, monoclonal gammopathy of undetermined significance and multiple myeloma
por: Sathitruangsak, Chirawadee, et al.
Publicado: (2016)

Primary pulmonary lymphoepithelioma‐like carcinoma treated with immunotherapy: A case report and literature review
por: Archwamety, Anita, et al.
Publicado: (2022)

Hepatitis C infection and renal cell carcinoma: A systematic review and meta-analysis
por: Wijarnpreecha, Karn, et al.
Publicado: (2016)

Real-World Evidence: Multicenter Efficacy and Toxicity Analysis of Nintedanib With Docetaxel as Second-Line Treatment in Mexican Patients With Advanced Lung Adenocarcinoma
por: Rodríguez-Cid, Jeronimo Rafael, et al.
Publicado: (2020)

Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis
por: Genuino, Anne Julienne, et al.
Publicado: (2019)

Real-life clinical pattern, management, and survival in Thai patients with early-stage or metastatic triple-negative breast cancer
por: Srimuninnimit, Vichien, et al.
Publicado: (2018)

Early-Onset Signet-Ring Cell Adenocarcinoma of the Colon: A Case Report and Review of the Literature
por: Khan, Maliha, et al.
Publicado: (2017)

Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines
por: Genuino, Anne Julienne, et al.
Publicado: (2019)

Breast Cancer Incidence Trends and Projections in Northeastern Thailand
por: Virani, Shama, et al.
Publicado: (2018)

Low Fat-Free Mass Index Measured by Bioelectrical Impedance Analysis Correlates With Hematologic Adverse Events in Early-Stage Breast Cancer Patients Receiving Chemotherapy: A Prospective Observational Cohort Study
por: Thanestada, Jirawat, et al.
Publicado: (2022)

Quantitative Superresolution Microscopy Reveals Differences in Nuclear DNA Organization of Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
por: Sathitruangsak, Chirawadee, et al.
Publicado: (2015)

Vimentin expression status is a potential biomarker for brain metastasis development in EGFR-mutant NSCLC patients
por: Teocharoen, Rattanawadee, et al.
Publicado: (2021)

Caffeine Induces G0/G1 Cell Cycle Arrest and Inhibits Migration through Integrin αv, β3, and FAK/Akt/c-Myc Signaling Pathway
por: Meisaprow, Pichitchai, et al.
Publicado: (2021)

ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy
por: Incharoen, Pimpin, et al.
Publicado: (2016)

Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis
por: Oranratnachai, Songporn, et al.
Publicado: (2021)

Successful treatment with docetaxel plus nintedanib in a patient with lung adenocarcinoma and pulmonary fibrosis: A case report and literature review
por: Zlatanova, Tanya, et al.
Publicado: (2022)

Safety and tolerability of weekly docetaxel plus nintedanib: A phase I trial after first-line chemotherapy failure in NSCLC
por: Westeel, Virginie, et al.
Publicado: (2023)

Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis
por: Ljubicic, Lidija, et al.
Publicado: (2023)

Artificial intelligence (AI) vs. human in hip fracture detection
por: Twinprai, Nattaphon, et al.
Publicado: (2022)

Nintedanib plus docetaxel after progression on first-line immunochemotherapy in patients with lung adenocarcinoma: Cohort C of the non-interventional study, VARGADO
por: Grohé, Christian, et al.
Publicado: (2022)

Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy
por: Atasilp, Chalirmporn, et al.
Publicado: (2020)

Tubulin acetylation enhances lung cancer resistance to paclitaxel-induced cell death through Mcl-1 stabilization
por: Wattanathamsan, Onsurang, et al.
Publicado: (2021)

Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib
por: Wind, Sven, et al.
Publicado: (2019)

Bullous pemphigoid associated with nintedanib
por: Hasson, Amelia M., et al.
Publicado: (2019)

Nintedanib plus Docetaxel after Immune Checkpoint Inhibitor Failure in Patients with Advanced Non-Small-Cell Lung Cancer: A Case Series
por: Hochmair, Maximilian Johannes, et al.
Publicado: (2022)

Effect of Insurance Type on Stage at Presentation, Surgical Approach, Tumor Recurrence and Cancer-Specific Survival in Resectable Non-Small Lung Cancer Patients
por: Siwachat, Sophon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cc7h2aquas16sihocfvcfp9le1